A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
Not all companies are created equal, and StockStory is here to surface the ones with real upside. Keeping that in mind, here are three cash-producing companies that don’t make the cut and some better opportunities instead.
Entegris (ENTG)
Trailing 12-Month Free Cash Flow Margin: 17.3%
With fabs representing the company’s largest customer type, Entegris (NASDAQ: ENTG) supplies products that purify, protect, and generally ensure the integrity of raw materials needed for advanced semiconductor manufacturing.
Why Do We Think ENTG Will Underperform?
- Products and services are facing end-market challenges during this cycle, as seen in its flat sales over the last two years
- Demand will likely be soft over the next 12 months as Wall Street’s estimates imply tepid growth of 15.2%
- Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital
At $167.55 per share, Entegris trades at 37.1x forward P/E. Read our free research report to see why you should think twice about including ENTG in your portfolio.
Trex (TREX)
Trailing 12-Month Free Cash Flow Margin: 17.2%
Addressing the demand for aesthetically-pleasing and unique outdoor living spaces, Trex Company (NYSE: TREX) makes wood-alternative decking, railing, and patio furniture.
Why Are We Bearish on TREX?
- Customers postponed purchases of its products and services this cycle as its revenue declined by 1.7% annually over the last two years
- Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 7.3 percentage points
- Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
Trex is trading at $43.83 per share, or 23.3x forward P/E. Check out our free in-depth research report to learn more about why TREX doesn’t pass our bar.
Envista (NVST)
Trailing 12-Month Free Cash Flow Margin: 8.7%
Uniting more than 30 trusted brands including Nobel Biocare, Ormco, and DEXIS under one corporate umbrella, Envista Holdings (NYSE: NVST) is a global dental products company that provides equipment, consumables, and specialized technologies for dental professionals.
Why Are We Out on NVST?
- Annual revenue growth of 3.4% over the last five years was below our standards for the healthcare sector
- Earnings per share fell by 7% annually over the last five years while its revenue grew, showing its incremental sales were much less profitable
- Push for growth has led to negative returns on capital, signaling value destruction, and its decreasing returns suggest its historical profit centers are aging
Envista’s stock price of $23.21 implies a valuation ratio of 14.8x forward P/E. Dive into our free research report to see why there are better opportunities than NVST.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
